Microbiology & Infectious Diseases

Delpazolid and sutezolid show strong efficacy and reduced toxicity in Phase 2 TB trials, offering safer alternatives to linezolid for drug-resistant TB treatment.

A UKHSA survey finds strong vaccine confidence among UK parents, with 87% trusting vaccine effectiveness and satisfaction high in NHS delivery and communication.

French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.

Global vaccine coverage has improved since 1980 but stalled and declined during COVID-19, with millions of zero-dose children concentrated in a few countries, risking setbacks to immunisation goals.

Early trial data show that olorofim may offer a valuable new option for patients with resistant invasive fungal infections.

High ICU admission rates and atypical features marked France’s recent M. pneumoniae epidemic, especially in those without early macrolide therapy.

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Delayed sputum conversion and poor outcomes are common in patients with bedaquiline-resistant TB, according to a new South African cohort study.